Emerging research suggests that biological sex and genetics may play a major role in how neurological disorders develop, progress, and respond to treatment. The findings, which will be presented at Neuroscience 2026, reveal important differences that could help researchers develop more personalized approaches to treating complex brain conditions. Neuroscience 2026 is the annual meeting of the Society for Neuroscience and the world’s largest source of emerging news about brain science and health.
Researchers are increasingly finding that certain neurological conditions can behave differently depending on a person’s biological sex and genetic makeup. Understanding these differences could lead to treatments better suited to each individual’s biology. Two conditions receiving particular attention are Alzheimer’s disease (AD), an incurable disorder that progressively damages memory and other brain functions, and fibromyalgia, a chronic illness marked by persistent pain and fatigue that affects 2-4% of the global population. According to the World Health OrganizationAlzheimer’s affects between 35 and 40 million people worldwide.
Menopause, Genetics, and Alzheimer’s Disease
Two of the new studies highlight how menopause and inherited genetic factors may influence Alzheimer’s vulnerability and treatment responses.
One investigation found that people carrying genetic risk factors for Alzheimer’s responded differently to menopause hormone therapy (MHT) compared with those without the same genetic risks. The effects also varied according to the particular combination of hormones used. These findings suggest that both genetic background and hormone therapy formulation deserve consideration when evaluating treatment options. (Mateja Perović, University of Toronto)
A separate study examined rodents undergoing menopause that also carried genetic risk factors for Alzheimer’s. Researchers observed that brain circuits responsible for memory became particularly vulnerable, providing evidence that menopause may represent an important period of increased susceptibility for women who are genetically predisposed to the disease. (Stephanie M. Perez, University of Texas Health Science Center at San Antonio)
Sex Differences in Chronic Pain and Brain Inflammation
The other two studies explored how biological sex influences pain sensitivity, immune activity, and the effects of inflammation on the brain.
In a mouse model of fibromyalgia, females continued to show heightened sensitivity to touch and stronger immune system activation compared with males. The findings suggest that the biological processes contributing to chronic pain may differ between sexes, potentially making treatments tailored to these differences more effective. (Yasmin Sahlloul, University of Cincinnati)
Another investigation uncovered differences in how prolonged intestinal inflammation influences the brain. Using a mouse model, researchers found that chronic gut inflammation affected brain function and Alzheimer’s related disease changes differently in males and females. The results provide additional evidence that biological sex may influence the relationship between inflammation and neurological disease. (Nurcan Kilic, University of North Dakota)
Toward More Personalized Treatments for Brain Disorders
Together, the four studies underscore the importance of examining sex and genetic differences when investigating neurological conditions. By identifying biological factors that influence disease progression and treatment responses, researchers hope to move toward more precise therapies for Alzheimer’s, fibromyalgia, and other difficult-to-treat brain disorders.
“These four studies illustrate the fascinating discoveries that can be made when focusing on female-specific biology or possible sex differences in AD-related symptoms and risk factors,” said Liisa Galea, PhD, Treliving Family Chair in Women’s Mental Health at Centre for Addiction and Mental Health and moderator of the press conference. “The research presented at Neuroscience 2026 helps us pinpoint the specific differences that may help us develop more targeted treatment using precision approaches, even for some of our most complex brain disorders.”
Source: www.sciencedaily.com



